Tetzlaff K - Search Results

1

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat^® device for maintenance treatment of COPD: comparison with the long-acting β₂-agonist formoterol.

Koch A, Watz H, Maleki-Yazdi MR, Bothner U, Tetzlaff K, Voß F, McGarvey L. Koch A, et al. Among authors: tetzlaff k. NPJ Prim Care Respir Med. 2017 Oct 23;27(1):60. doi: 10.1038/s41533-017-0059-1. NPJ Prim Care Respir Med. 2017. PMID: 29061968 Free PMC article. Clinical Trial.

2

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Fležar M, Hébert J, McGarvey L, Pizzichini E, Reid J, Veale A, Grönke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E. Buhl R, et al. Among authors: tetzlaff k. Eur Respir J. 2015 Apr;45(4):969-79. doi: 10.1183/09031936.00136014. Epub 2015 Jan 8. Eur Respir J. 2015. PMID: 25573406 Free PMC article. Clinical Trial.

3

One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis.

McGarvey L, Niewoehner D, Magder S, Sachs P, Tetzlaff K, Hamilton A, Korducki L, Bothner U, Vogelmeier C, Koch A, Ferguson GT. McGarvey L, et al. Among authors: tetzlaff k. COPD. 2015;12(5):484-93. doi: 10.3109/15412555.2014.991864. Epub 2015 Feb 18. COPD. 2015. PMID: 25692310 Free PMC article. Clinical Trial.

4

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.

Buhl R, Magder S, Bothner U, Tetzlaff K, Voß F, Loaiza L, Vogelmeier CF, McGarvey L. Buhl R, et al. Among authors: tetzlaff k. Respir Med. 2017 Jan;122:58-66. doi: 10.1016/j.rmed.2016.11.011. Epub 2016 Nov 14. Respir Med. 2017. PMID: 27993292 Free article. Clinical Trial.

5

Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.

Magnussen H, Watz H, Kirsten A, Decramer M, Dahl R, Calverley PM, Towse L, Finnigan H, Tetzlaff K, Disse B. Magnussen H, et al. Among authors: tetzlaff k. Respir Med. 2014 Apr;108(4):593-9. doi: 10.1016/j.rmed.2014.01.002. Epub 2014 Jan 15. Respir Med. 2014. PMID: 24477080 Free article. Clinical Trial.

6

Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.

Magnussen H, Tetzlaff K, Bateman ED, Watz H, Kirsten AM, Wouters EF, Disse B, Finnigan H, Rodriguez-Roisin R, Calverley PM. Magnussen H, et al. Among authors: tetzlaff k. Eur Respir J. 2016 Feb;47(2):651-4. doi: 10.1183/13993003.01644-2015. Epub 2015 Nov 19. Eur Respir J. 2016. PMID: 26585433 Free article. Clinical Trial. No abstract available.

7

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.

Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM. Watz H, et al. Among authors: tetzlaff k. Lancet Respir Med. 2016 May;4(5):390-8. doi: 10.1016/S2213-2600(16)00100-4. Epub 2016 Apr 7. Lancet Respir Med. 2016. PMID: 27066739 Clinical Trial.

8

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.

Watz H, Tetzlaff K, Magnussen H, Mueller A, Rodriguez-Roisin R, Wouters EFM, Vogelmeier C, Calverley PMA. Watz H, et al. Among authors: tetzlaff k. Respir Res. 2018 Dec 13;19(1):251. doi: 10.1186/s12931-018-0944-3. Respir Res. 2018. PMID: 30545350 Free PMC article. Clinical Trial.

9

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline.

Ferguson GT, Shaikh A, Tetzlaff K, Mueller A, Magnussen H, Watz H. Ferguson GT, et al. Among authors: tetzlaff k. Int J Chron Obstruct Pulmon Dis. 2020 Nov 11;15:2879-2888. doi: 10.2147/COPD.S237408. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33204084 Free PMC article.

10

Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.

Calverley PMA, Tetzlaff K, Vogelmeier C, Fabbri LM, Magnussen H, Wouters EFM, Mezzanotte W, Disse B, Finnigan H, Asijee G, Hallmann C, Watz H. Calverley PMA, et al. Among authors: tetzlaff k. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1219-1221. doi: 10.1164/rccm.201612-2525LE. Am J Respir Crit Care Med. 2017. PMID: 28306321 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page